BYCROSS
Atherectomy Catheter
Abluminus DES+
Sirolimus coated stent
ABLUMINUS DES+ was developed from the proprietary ENVISOLUTION technology to address unmet clinical needs in patients with diabetes mellitus and acute myocardial infarction with coronary artery disease.
Advantages
- • Sirolimus acts cytostatic - not cytotoxic
- • Optimum Sirolimus binding to the balloon surface thanks to Nanolute technology
- • 100% balloon coating
- • Slow tissue absorption
- • Effective Sirolimus transfer into deeper vessel layers
- • High Sirolimus bioavailability
Specifications
Abluminal Coating
Facilitate mono directional drug release and less systemic exposure of drug leading to faster re-endothelistation
Fusion Coating
Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis
Edge Coating
The additional 0.5mm coating on the edge of the balloon which addresses the edge restenosis
Biodegradable Film
The formation of circular film with biodegradable polymer facilitate maximum drug delivery in blood wet conditions
Abluminus DES+ Brochure
Additional Information
For more information about this product click here.
